Contents
Current Vascular Pharmacology, Volume 5 - Number 3
Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]
, 5(3): 173 - 174Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros
DOI: 10.2174/157016107781024145
Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
, 5(3): 175 - 184John C. Ashton and Paul F. Smith
DOI: 10.2174/157016107781024109
Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management
, 5(3): 185 - 194Joachim R. Ehrlich, Stanley Nattel and Stefan H. Hohnloser
DOI: 10.2174/157016107781024073
Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease
, 5(3): 195 - 209Dimitrios Mikroulis, Nikolaos Papanas, Efstratios Maltezos and Georgios Bougioukas
DOI: 10.2174/157016107781024136
New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation
, 5(3): 211 - 219Matthias Hammwohner, Alessandra D'Alessandro, Oliver Wolfram and Andreas Goette
DOI: 10.2174/157016107781024118
Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
, 5(3): 227 - 237Polychronis Dilaveris, Georgios Giannopoulos, Maria Riga, Andreas Synetos and Christodoulos Stefanadis
DOI: 10.2174/157016107781024091
The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
, 5(3): 239 - 248Martin Smollich and Pia Wulfing
DOI: 10.2174/157016107781024082
Webmaster Contact: info@benthamscience.net